STRATA CRITICAL MEDICAL, INC. (SRTA)

STRATA CRITICAL MEDICAL, INC. (SRTA) scores 56 out of 100 on boothcheck's 11-model valuation framework. Verdict: Fair The estimated fair value is 3.14, representing a 24% premium to fair value. Quantitative score: 64/100. Qualitative score: 50/100.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full SRTA analysis on boothcheck